Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Berry Button"'
Autor:
Karen Cravero, Morgan V. Pantone, Dong Ho Shin, Riley Bergman, Rory Cochran, David Chu, Daniel J. Zabransky, Swathi Karthikeyan, Ian G. Waters, Natasha Hunter, D. Marc Rosen, Kelly Kyker-Snowman, W. Brian Dalton, Berry Button, Dan Shinn, Hong Yuen Wong, Joshua Donaldson, Paula J. Hurley, Sarah Croessmann, Ben Ho Park
Publikováno v:
Oncotarget. 13:373-386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d82f6833d2b7f0af1eb5d4c06c2f7ceb
https://doi.org/10.18632/oncotarget.28200
https://doi.org/10.18632/oncotarget.28200
Autor:
Ashley Cimino-Mathews, Sarah J. Wheelan, Ben H. Park, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, David Chu, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Daniel J. Zabransky, Christopher D. Gocke, Katie Beierl, Bracha Erlanger Avigdor
Supplemental figure S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029c9ccd62b7e667e0a2138caf1e52e9
https://doi.org/10.1158/1078-0432.22462722.v1
https://doi.org/10.1158/1078-0432.22462722.v1
Autor:
Ashley Cimino-Mathews, Sarah J. Wheelan, Ben H. Park, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, David Chu, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Daniel J. Zabransky, Christopher D. Gocke, Katie Beierl, Bracha Erlanger Avigdor
Purpose: Although most human cancers display a single histology, there are unusual cases where two or more distinct tissue types present within a primary tumor. One such example is metaplastic breast carcinoma, a rare but aggressive cancer with a het
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6375bf8d29e61d0805a0723f6253cbc3
https://doi.org/10.1158/1078-0432.c.6525186.v1
https://doi.org/10.1158/1078-0432.c.6525186.v1
Autor:
Ben Ho Park, James M. Rae, Daniel F. Hayes, Paula J. Hurley, Josh Lauring, Karen S. Jacks, Dan Robinson, Anne Schott, Arul M. Chinnaiyan, Nahomi Tokudome, Kimberly Aung, Arielle Medford, Riaz Gillani, W. Brian Dalton, Heather A. Parsons, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Bracha Erlanger, Sarah Croessmann, Justin Cidado, Patricia Valda Toro, Hong Yuen Wong, Rory L. Cochran, Daniel J. Zabransky, Dustin A. VanDenBerg, Christina Gersch, Costanza Paoletti, David Chu
Purpose: Mutations in the estrogen receptor (ER)α gene, ESR1, have been identified in breast cancer metastases after progression on endocrine therapies. Because of limitations of metastatic biopsies, the reported frequency of ESR1 mutations may be u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::534a487fe4c889efedb3411fac792aa9
https://doi.org/10.1158/1078-0432.c.6524730.v1
https://doi.org/10.1158/1078-0432.c.6524730.v1
Autor:
Ashley Cimino-Mathews, Sarah J. Wheelan, Ben H. Park, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, David Chu, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Daniel J. Zabransky, Christopher D. Gocke, Katie Beierl, Bracha Erlanger Avigdor
Supplemental table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4ac7e2d4f16cb149dfe7a4db8bfa84
https://doi.org/10.1158/1078-0432.22462731.v1
https://doi.org/10.1158/1078-0432.22462731.v1
Autor:
Ben Ho Park, James M. Rae, Daniel F. Hayes, Paula J. Hurley, Josh Lauring, Karen S. Jacks, Dan Robinson, Anne Schott, Arul M. Chinnaiyan, Nahomi Tokudome, Kimberly Aung, Arielle Medford, Riaz Gillani, W. Brian Dalton, Heather A. Parsons, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Bracha Erlanger, Sarah Croessmann, Justin Cidado, Patricia Valda Toro, Hong Yuen Wong, Rory L. Cochran, Daniel J. Zabransky, Dustin A. VanDenBerg, Christina Gersch, Costanza Paoletti, David Chu
Supplementary Methods Figure S1 ESR1 Y537SY537N and D538G probes are mutation specific. Figure S2 Patient 1 and Patient 14's plasma DNA. Table S1 Additional patient characteristics. Table S2 Primers used in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855945fa1c6829c1a0e7375846b80ee8
https://doi.org/10.1158/1078-0432.22461237
https://doi.org/10.1158/1078-0432.22461237
Autor:
Ashley Cimino-Mathews, Sarah J. Wheelan, Ben H. Park, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, David Chu, Berry Button, Kelly Kyker-Snowman, Karen Cravero, Daniel J. Zabransky, Christopher D. Gocke, Katie Beierl, Bracha Erlanger Avigdor
vcf files for 16 WES samples analyzed in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53f4c77cedfd0c7918b0968104cfe91
https://doi.org/10.1158/1078-0432.22462716.v1
https://doi.org/10.1158/1078-0432.22462716.v1
Autor:
Karen Cravero, Arielle Medford, Aparna Pallavajjala, Jenna Canzoniero, Natasha Hunter, David Chu, Rory L. Cochran, Ian Waters, Eric S. Christenson, Kelly Kyker-Snowman, Berry Button, Alex J. Cole, Ben Ho Park
Publikováno v:
Practical Laboratory Medicine, Vol 12, Iss , Pp - (2018)
Background: Genomic testing is often limited by the exhaustible nature of human tissue and blood samples. Here we describe biotinylated amplicon sequencing (BAmSeq), a method that allows for the creation of PCR amplicon based next-generation sequenci
Externí odkaz:
https://doaj.org/article/3e2495c1fac645eb88e783d29a514742
Autor:
Paula J. Hurley, Brad A. Davidson, Daniel J. Zabransky, Swathi Karthikeyan, Ian Waters, Morgan V. Pantone, Melinda E. Sanders, Karen Cravero, Hong Yuen Wong, Kelly Kyker-Snowman, Berry Button, Violeta Sanchez, Riley E. Bergman, D. Marc Rosen, Sarah C. Reed, Ben Ho Park, Joshua Donaldson, David Chu, Sarah Croessmann, Lauren Dennison, Paula I. Gonzalez-Ericsson, Dong Ho Shin
Publikováno v:
J Clin Invest
Intratumor heterogeneity is an important mediator of poor outcomes in many cancers, including breast cancer. Genetic subclones frequently contribute to this heterogeneity; however, their growth dynamics and interactions remain poorly understood. PIK3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9904403f650875edfd0e0be6a6a8cbf
https://doi.org/10.1172/jci143557
https://doi.org/10.1172/jci143557
Autor:
Daniel J. Zabransky, David Chu, Tasha Hunter, Lauren Dennison, Cody Ramin, Richard B.S. Roden, Karen Cravero, Swathi Karthikeyan, W. Brian Dalton, Kelly Kyker-Snowman, Berry Button, Ian Waters, D. Marc Rosen, Betty J. May, Eric S. Christenson, Ben Ho Park, Dana Petry, Kala Visvanathan, Sarah Croessmann, Josh Donaldson, Deborah K. Armstrong
Publikováno v:
Breast Cancer Research and Treatment. 174:401-412
PURPOSE: Estrogen receptor-alpha (ER) is a therapeutic target of ER positive (ER+) breast cancers. Although ER signaling is complex, many mediators of this pathway have been identified. Specifically, phosphorylation of ER at serine 118 affects respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4c34d039e6cb5743610567294942d2
https://doi.org/10.1007/s10549-018-05087-7
https://doi.org/10.1007/s10549-018-05087-7